It matters because it sets privacy and security expectations for consumer health data beyond traditional healthcare settings. Security teams need to identify where this data is collected, shared, or disclosed, restrict third-party tracking and advertising use, and support retention, consent, and incident-response controls that match the law’s disclosure and notice requirements.
What security teams need to understand about the law’s scope
The practical significance for security is that the law reaches consumer health data outside the traditional healthcare perimeter. That changes where teams look for regulated data, which vendors and trackers are in scope, and how they define sensitive-data handling across websites, apps, analytics tags, adtech, support tooling, and data-sharing pipelines.
For many organisations, the first failure is not weak encryption or a missed patch, but incomplete data mapping. If teams do not know where consumer health data is collected, inferred, disclosed, or retained, they cannot apply the right notice, consent, deletion, or sharing controls consistently.
That makes the law a cross-functional security and privacy problem, not just a legal review item. Security teams need enough visibility into data flows to distinguish ordinary telemetry from data that can reveal health status, treatment interest, or related consumer signals.
Why tracking, advertising, and sharing controls matter
The law matters because a lot of risk sits in third-party collection and onward disclosure rather than in the core application itself. Security teams need to understand which scripts, SDKs, pixels, and integrations can move consumer health data to external parties, since those paths can create both compliance exposure and reputational damage.
That usually means more than a policy statement. Teams need technical guardrails for tag governance, content security, vendor review, data minimisation, and explicit controls over when data can be used for advertising or cross-context tracking. The control objective is to make unauthorised sharing difficult, visible, and reviewable.
Linking privacy review to engineering controls also helps avoid a common gap: a product team may believe a disclosure is “consented,” while the actual implementation continues to send the same data to multiple downstream services. Security review should verify the real data path, not just the intended one.
How incident response, retention, and notice expectations change
Security teams also need to adjust operational controls around retention, incident response, and evidence preservation. If consumer health data is treated like ordinary marketing data, it may be kept too long, copied into too many systems, or deleted inconsistently, which increases exposure if a breach or misuse occurs.
Retention discipline matters because the less data that exists, the less can be exposed, subpoenaed, or abused. Notice and response workflows matter because the legal obligations around disclosure and consent mean the organisation needs to reconstruct what data existed, where it flowed, and which parties received it.
That is why incident preparation should include data-location inventories, vendor contact paths, logging that can prove disclosure decisions, and a tested process for identifying whether consumer health data was involved in an event. If teams cannot answer that quickly, they will struggle to assess impact accurately.
Risk and Threat Considerations
Consumer health data often spreads through adtech, analytics, and third-party services before security teams recognise it as sensitive. The risk is that a routine website or app integration can create a regulated disclosure path, then preserve that exposure through retention, re-sharing, or weak vendor oversight.
Failure mechanism: Teams misclassify consumer health data as standard behavioural or marketing data, so scripts, SDKs, support tools, and downstream processors collect or disclose it without the controls needed to limit sharing, retention, or notice obligations.
Impact: The organisation can lose control over where the data goes, increase breach and misuse exposure, and face compliance failures that are difficult to unwind once the data has been distributed across multiple third parties.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
NIST CSF 2.0 and NIST SP 800-53 Rev 5 set the technical controls, while ISO/IEC 27001:2022 defines the regulatory obligations.
| Framework | Control / Reference | Relevance |
|---|---|---|
| NIST CSF 2.0 | GV.OC-01 — Organizational Context | State privacy scope shapes enterprise risk context for consumer health data. |
| ID.GV-01 — Cybersecurity Policy | The topic requires policy-backed handling rules for collection, sharing, retention, and notice. | |
| Recommendation — Map consumer health data processing into the organisation’s risk context and obligations. Define and enforce policy for consumer health data handling, disclosure, and retention. | ||
| NIST SP 800-53 Rev 5 | AR-2 — Privacy Impact and Risk Assessment | Consumer health data handling needs privacy risk assessment across collection and disclosure paths. |
| AU-2 — Event Logging | Teams need evidence to reconstruct disclosures and incident scope for regulated data. | |
| Recommendation — Assess privacy risk for consumer health data collection, sharing, and retention. Log key data-sharing and disclosure events for later investigation and notice decisions. | ||
| ISO/IEC 27001:2022 | A.5.34 — Privacy and protection of PII | The law’s handling expectations align with privacy controls for sensitive consumer data. |
| Recommendation — Apply privacy controls to govern collection, use, retention, and disclosure of consumer health data. | ||
Practitioner Guidance
What to prioritise: Start with a data-flow review that identifies every place consumer health data is collected, inferred, tagged, exported, or retained. That inventory should include websites, mobile apps, advertising technology, analytics, customer support, and vendor integrations, not only core product databases.
What to verify: Confirm that consent, disclosure, retention, and deletion controls match actual implementation. If a product or site can send data to third parties before a user choice is recorded, or can reuse the data for advertising by default, treat that as a control failure rather than a documentation issue.
Practitioner takeaway: The key security question is whether your data controls follow the real disclosure path. If you cannot prove where consumer health data goes, who receives it, and how long it persists, you do not yet have a defensible operating model.
Related resources from NHI Mgmt Group
- How should organisations prepare for the Washington My Health My Data Act before it takes effect?
- Why does collecting consumer health data under the Washington My Health My Data Act create higher compliance risk?
- What are the signs that a consumer health data program is failing under the Washington My Health My Data Act?
- What is the difference between consumer health data and personal information in the Washington My Health My Data Act?
Deepen Your Knowledge
Free weekly newsletter
Subscribe to the NHI & AI Identity Journal
The latest on NHI and Agentic AI security – articles, research, breaches, news and events every week.
Bonus 33% off our NHI Course when you subscribe.
Reviewed and updated by the NHIMG editorial team on October 17, 2026.
NHI Mgmt Group — the #1 independent authority on Non-Human Identity, IAM, and Agentic AI security. nhimg.org